PRECISION IMMUNOLOGY LABORATORY SHARED RESOURCE (PIL) The Precision Immunology Laboratory Shared Resource (PIL) is a highly restructured PCC Shared Resource designed to comprehensively study immune cell phenotype and function. The mission of PIL is to characterize and understand anti-tumor immune responses, determine mechanisms by which immune escape and evasion occur, and predict patient responses to cancer immunotherapy, in support of Perlmutter Cancer Center (PCC) investigators. Under the direction of world-recognized immune monitoring expert Dr. Pratip Chattopadhyay, formerly of the NIH Vaccine Center, PIL offers a wide range of services for immune monitoring, including high quality cell processing and immunoassays for PCC clinical trials, with rigorous quality control and bioinformatics capabilities to interpret the results. PIL also provides a wide range of flow cytometry services (including education) for basic, population and clinical researchers at PCC, and applies cutting-edge technology for high parameter, single cell immune analysis, that provides results that are robust, accessible, and interpretable by researchers and clinicians.
The Specific Aims of PIL are:
Aim 1) To provide high-quality cell processing and immunoassays for PCC clinical trials with vigorous quality control and bioinformatics capabilities;
Aim 2) To provide a wide range of flow cytometry services, including education;
Aim 3) To develop and apply cutting-edge technology for high parameter, single cell immune analysis providing robust results no generally available elsewhere.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016087-38
Application #
9633412
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
2024-02-29
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
38
Fiscal Year
2019
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Xu, Yang; Taylor, Paul; Andrade, Joshua et al. (2018) Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma. Cancer Res 78:6539-6548
Gagner, Jean-Pierre; Zagzag, David (2018) Probing Glioblastoma Tissue Heterogeneity with Laser Capture Microdissection. Methods Mol Biol 1741:209-220
Tsay, Jun-Chieh J; Wu, Benjamin G; Badri, Michelle H et al. (2018) Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med 198:1188-1198
Martin, Patricia K; Marchiando, Amanda; Xu, Ruliang et al. (2018) Autophagy proteins suppress protective type I interferon signalling in response to the murine gut microbiota. Nat Microbiol 3:1131-1141
de la Parra, Columba; Ernlund, Amanda; Alard, Amandine et al. (2018) A widespread alternate form of cap-dependent mRNA translation initiation. Nat Commun 9:3068
Coux, Rémi-Xavier; Teixeira, Felipe Karam; Lehmann, Ruth (2018) L(3)mbt and the LINT complex safeguard cellular identity in the Drosophila ovary. Development 145:
Patibandla, Jay R; Fehniger, Julia E; Levine, Douglas A et al. (2018) Small cell cancers of the female genital tract: Molecular and clinical aspects. Gynecol Oncol 149:420-427
Fanok, Melania H; Sun, Amy; Fogli, Laura K et al. (2018) Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. J Invest Dermatol 138:1116-1125
Harper, Lamia; Balasubramanian, Divya; Ohneck, Elizabeth A et al. (2018) Staphylococcus aureus Responds to the Central Metabolite Pyruvate To Regulate Virulence. MBio 9:
Berger, Ashton C; Korkut, Anil; Kanchi, Rupa S et al. (2018) A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Cancer Cell 33:690-705.e9

Showing the most recent 10 out of 1170 publications